Published in Am J Clin Nutr on July 08, 2015
Preventing Obesity Using Novel Dietary Strategies | NCT00072995
Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome. Front Neurosci (2016) 0.77
Gene-Diet Interaction and Precision Nutrition in Obesity. Int J Mol Sci (2017) 0.75
Markers of dietary protein intake are associated with successful weight loss in the POUNDS Lost trial. Clin Obes (2017) 0.75
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med (2009) 12.38
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr (1998) 8.97
Beyond diathesis stress: differential susceptibility to environmental influences. Psychol Bull (2009) 7.38
Obesity wars: molecular progress confronts an expanding epidemic. Cell (2004) 5.29
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med (2007) 3.36
Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes (2002) 2.90
Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65
Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis (2013) 2.33
Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab (2006) 1.93
NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides (2004) 1.63
Adherence is a multi-dimensional construct in the POUNDS LOST trial. J Behav Med (2009) 1.53
Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation (2011) 1.37
A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med (2005) 1.25
Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet (2009) 1.20
A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Biochim Biophys Acta (2004) 1.15
Early dietary intervention: long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers. Am J Physiol Endocrinol Metab (2005) 1.10
Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat tissue function. J Am Geriatr Soc (1997) 1.04
Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res (1995) 0.95
Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Am J Physiol Endocrinol Metab (2007) 0.94
Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial. Hypertension (2012) 0.94
Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept (2005) 0.93
Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke. Clin Biochem (2009) 0.89
Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity. Obesity (Silver Spring) (2011) 0.87
Hypothalamus-adipose tissue crosstalk: neuropeptide Y and the regulation of energy metabolism. Nutr Metab (Lond) (2014) 0.84
Polymorphisms in the neuropeptide Y gene and the risk of obesity: findings from two prospective cohorts. J Clin Endocrinol Metab (2011) 0.83
Neuropeptide Y and cardiovascular regulation. Curr Opin Nephrol Hypertens (1993) 0.82
Influence of variants in the NPY gene on obesity and metabolic syndrome features in Spanish children. Peptides (2013) 0.82
Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression. Peptides (2012) 0.81
Hypothalamic neuropeptide Y and plasma leptin after long-term high-fat feeding in the rat. Neurosci Lett (1998) 0.81
Differential expression and localization of neuropeptide Y peptide in pancreatic islet of diabetic and high fat fed rats. Peptides (2014) 0.80
The role of the neuropeptide Y2 receptor in liporemodeling: neuropeptide Y-mediated adipogenesis and adipose graft maintenance. Plast Reconstr Surg (2009) 0.79
Increasing association between a neuropeptide Y promoter polymorphism and body mass index during the course of development. Pediatr Obes (2012) 0.77
Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials. Am J Clin Nutr (2016) 0.75